INGN
Inogen, Inc. (NASDAQ)
Healthcare — Medical Devices
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Price History
Fundamentals
| Market Cap | $180.05M |
| P/E Ratio (TTM) | - |
| Forward P/E | -25.58 |
| EPS (TTM) | $-0.91 |
| Dividend Yield | - |
| Profit Margin | -7.08% |
| Revenue Growth | 3.40% |
| ROE | -13.07% |
| Debt/Equity | 9.26 |
| Recommendation | None |
| Analyst Target | $12.67 |
| Analysts | 3 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 51.7 |
| Beta | 1.60 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $9.13 |
| 52-Week Low | $5.34 |
| 50-Day Avg | $6.65 |
| 200-Day Avg | $6.87 |
| Avg Volume | 343.3K |
| Volume | 260.9K |
Performance Analysis
NEUTRALINGN presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:15 UTC
Back to Screener Export Report